Sfoglia per Autore
In vitro metabolism of 2-(5-ethylpyridin-2-yl)benzimidazole.
1988-01-01 Caputo O.; Grosa G.; Balliano G.; Rocco F.; Biglino G.
In vivo metabolism of the anti-inflammatory agent 2-(ethylpyridin-2-yl)benzimidazole.
1989-01-01 Caputo O.; Grosa G.; Ceruti M.; Viola F.; Rocco F.
In vitro metabolism of 7-(1,3-thiazolidin-2ylmethyl)theophylline: the metabolic fate of the 1,3-thiazolidine ring.
1990-01-01 Grosa G.; Ceruti M.; Caputo O.; Rocco F.; Biglino G.
Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes.
1990-01-01 Caputo O.; Grosa G.; Ceruti M.; Rocco F.; Biglino G.
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity.
1991-01-01 Ceruti M.; Grosa G.; Rocco F.
Total synthesis of the hypocholesterolemic and antifungal drug 10-azasqualene 2,3-epoxide, the first non-cyclized analogue of the C-8 carbonium ion formed during squalene epoxide cyclization.
1991-01-01 Ceruti M.; Rocco F.; Grosa G.; Cattel L.
Studio del metabolismo del nuovo analgesico “D-16120” con microsomi di fegato di ratto.
1991-01-01 Caputo O.; Grosa G.; Rocco F.
The metabolic fate of the anti-parkinsonian drug budipine in rats.
1991-01-01 Caputo O.; Grosa G.; Ceruti M.; Rocco F.; Biglino G.
The in vitro metabolism of 1,3-thiazolidine derivatives of theophylline: a study on structure-metabolism correlation.
1991-01-01 Grosa G.; Ceruti M.; Caputo O.; Rocco F.; Biglino G.
Synthesis and inhibition of cholesterol biosynthesis by azasqualene alcohol and derivatives.
1992-01-01 Rocco F.; Ceruti M.; Grosa G.; Cattel L.
Synthesis of HEI analogues of the C-20 carbocation forming during lanosterol biosynthesis, as hypocholesterolemics.
1992-01-01 Ceruti M.; Rocco F.; Grosa G.; Brusa P.; Cattel L.
Azasqualene alcohol and derivatives. New selective inhibitors of 2,3-oxidosqualene cyclase.
1992-01-01 Ceruti M.; Viola F.; Balliano G.; Grosa G.; Rocco F.
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase.
1992-01-01 Grosa G.; Milla P.; Ceruti M.; Brusa P.; Rocco F.; Cattel L.
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
1992-01-01 Ceruti M.; Balliano G.; Viola F.; Grosa G.; Rocco F.; Cattel L.
Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase.
1993-01-01 Ceruti M.; Rocco F.; Viola F.; Balliano G.; Grosa G.; Dosio F.; Cattel L.
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study.
1993-01-01 Grosa G.; Rocco F.; Ceruti M.; Dosio F.; Brusa P.; Biglino G.
Novel high-energy intermediate analogues and site-directed inhibitors of 2,3-oxidosqualene cyclase.
1994-01-01 Ceruti M.; Rocco F.; Grosa G.; Cattel L.
Inhibitors of 2,3-oxidosqualene cyclase as hypocholesterolemic and antifungal drugs.
1994-01-01 Ceruti M.; Viola F.; Balliano G.; Rocco F.; Cattel L.
Synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene.
1994-01-01 Ceruti M.; Grosa G.; Rocco F.; Cattel L.
Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl)- piperazine by rat liver microsomes.
1994-01-01 CAPUTO O.; ROCCO F.; GROSA G.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile